toggle

Sage Therapeutics Inc

Latest Sage Therapeutics Inc News and Updates

Company & Industry Overviews
Sage Therapeutics’ GABA Receptor–Based Products
On June 12, Sage Therapeutics announced its expedited development plan for SAGE-217.
By Mike BensonJuly 13 2018, Updated 10:32 a.m. ET

ABOUT Market Realist
About Us
Privacy Policy
Terms of Use
DMCA

CONNECT with Market Realist

© Copyright 2024 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Sage Therapeutics Inc

Sage Therapeutics’ GABA Receptor–Based Products